Paul Kaufman, asst U.S. attorney, chief of civil health care fraud, U.S. Attorney's Office Eastern Dist of NY; Antionia F. Giuliana and William Escobar, Kelley, Drye & Warren, LLP; Damon Strickland, Eli Lily & Co., Inc.; Stephen A. Mansfield, Akin Gump Strauss Hauer & Feld LLP
The American Conference Institute has scheduled Fraud and Abuse in the Sale and Marketing of Drugs on Tuesday and Wednesday, March 27 and 28, at the New York Marriott Downtown, 85 West Street in Manhattan.
On Tuesday it runs from 9:00 a.m. to 5:15 p.m. and on Wednesday from 8:45 a.m. to 5:00 p.m.
The conference will unite industry leaders, expert practitioners, top prosecutors and leading in-house counsel and compliance executives for an in-depth examination of landmark cases involving individual liability for executives and in-house counsel. The speakers will offer detailed discussions of the Foreign Corrupt Practices Act, useful guidance on aggregate spend reporting requirements, and an analysis of critical federal appellate and Supreme Court opinions.
Other topics are Avoiding Individual Accountability: How to Steer Clear of Prosecution and Exclusion Under the Responsible Corporate Officer Doctrine; Analyzing the Broadened Use of the False Claims Act and its implications for Pharma; and Government Spotlight: Identifying Federal and State Enforcement Priorities.
Among the faculty are Mark Mansour and Stephen P. Mansfield, Akin, Gump, Strauss, Hauer, & Feld, LLP; Joseph Savage, Jr., Goodwin Procter LLP; William Escobar, Kelley Drye & Warren LLP; and Paula Taylor-Whitfield, deputy general counsel, Eli Lilly & Co., Inc.
To register for this event visit www.AmericanConference.com/FADrugs or call (888) 224-2480.